Valuation (45%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.29 | N/A |
| PEG Ratio (TTM) | 13.85 | N/A |
| P/S Ratio (TTM) | 1.84 | N/A |
| P/B Ratio (TTM) | 3.37 | N/A |
| P/FCF Ratio (TTM) | 143.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 43.38 | N/A |
| Price to 5YR AVG FCF Ratio | 70.66 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.02% | N/A |
| ROE (TTM) | 11.65% | N/A |
| Net Profit Margin (TTM) | 5.74% | N/A |
| ROIC 5YR AVG | 11.22% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 258.94% | 518.14% | 317.16% |
| Revenue | 1.37% | 1.54% | 4.54% |
| Net Income | 4.15% | 503.99% | 308.67% |
| Cash Flow | 87.90% | 14.36% | 9.40% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.10 | N/A |
| Quick Ratio (TTM) | 1.27 | N/A |
| D/E Ratio (TTM) | 0.47 | N/A |
| Interest Coverage (TTM) | 6.24 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.14 | N/A |
| LTL to 5YR AVG FCF | 9.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.70% | N/A |